Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

389.51 +10.59 (+2.79%)
Delayed Quote Updated: 1:23 PM EST, Nov 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Natera, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
News headline image
Stanley Druckenmiller Has Bet Big on This 1 Healthcare Stock. Here's Why I Disagree. ↗
The business is promising, but the valuation today has gone to the stratosphere. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Why Natera (NTRA) Stock Is Up Today
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA) jumped 2.4% in the afternoon session after the company announced that incorporating pha... 
Via StockStory
News headline image
Why Natera (NTRA) Stock Is Up Today
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA) jumped 1.7% in the morning session after the U.S. Food and Drug Administration granted ... 
Via StockStory
News headline image
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that ca... 
Via StockStory
News headline image
1 Unpopular Stock That Deserves Some Love and 2 Facing Challenges
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fea... 
Via StockStory
News headline image
2 Growth Stocks to Stash and 1 That Underwhelm
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market va... 
Via StockStory
News headline image
1 Unprofitable Stock to Target This Week and 2 We Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar
Check out the companies making headlines yesterday: AutoZone (NYSE:AZO): Auto parts and accessories retailer AutoZone (NYSE:AZO) rose by 6.1% on Tuesday afte... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Natera (NTRA) Stock Soaring Today
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA) jumped 5.2% in the afternoon session after the company announced that Japan's Pharmaceu... 
Via StockStory
News headline image
Natera CEO Steven Chapman Sells 1,698 Shares for $545,000 ↗
The sale was executed under a pre-arranged Rule 10b5-1 plan amended in March 2026, leaving Chapman with 98,199 directly held shares. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Surprising Stock Has Been Stanley Druckenmiller's No. 1 Position for 8 Straight Quarters. Is It a No-Brainer Buy? ↗
The well-respected investor has Meta Platforms, Delta Air Lines, and Eli Lilly in his family office's portfolio. The stock isn't one of those. 
Via The Motley Fool
News headline image
3 Reasons Investors Love Natera (NTRA)
What a time it’s been for Natera. In the past six months alone, the company’s stock price has increased by a massive 59.9%, reaching $328.13 per share. This ... 
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia) ↗
His largest position today is a bet on genomics. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Here’s How Much You Would Have Made Owning Natera Stock In The Last 10 Years ↗
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 27.54% on an annualized basis producing an average annual return of 40.97%. Currently, Natera has a market capitalization of... 
Via Benzinga
News headline image
3 Momentum Stocks to Own for Decades
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, u... 
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Has Roughly 17% of His $5.2 Billion Duquesne Portfolio in Natera Stock. Is It Still a Buy After an 80% Run? ↗
The billionaire has good reasons to like this genetic testing leader. 
Via The Motley Fool
News headline image
3 Healthcare Stocks with Promising Prospects
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
Billionaire Stanley Druckenmiller Is Quietly Loading Up on Healthcare Stocks -- Here's What His New Positions Reveal ↗
Duquesne Family Office has beefed up its healthcare holdings. 
Via The Motley Fool
News headline image
Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either. ↗
Natera's growth, expanding role in cancer care, and growing diagnostic data platform help explain why Druckenmiller has made it a major portfolio holding, despite valuation and regulatory risks. 
Via The Motley Fool
News headline image
3 Large-Cap Stocks Worth Investigating
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new are... 
Via StockStory
News headline image
2 Biotech Stocks Shaping Up for Major Breakouts ↗
Moderna's mRNA cancer vaccine breakthrough with Merck fueled a biotech rally, with the IBB near highs. Eli Lilly and Natera both show strong uptrends and possible breakouts. 
Via MarketBeat
Topics ETFs
News headline image
Billionaire Stanley Druckenmiller's Top Holding Is Up 37% This Year. Is the Market Pricing in the Full Story? ↗
The hedge fund legend has bet much of the family office on this one diagnostics company. 
Via The Motley Fool
News headline image
Here's How Much $1000 Invested In Natera 10 Years Ago Would Be Worth Today ↗
Natera (NASDAQ:NTRA) has outperformed the market over the past 10 years by 27.63% on an annualized basis producing an average annual return of 40.99%. Currently, Natera has a market capitalization of... 
Via Benzinga
News headline image
Q2 Rundown: Natera (NASDAQ:NTRA) Vs Other Biotechnology Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how biotechnology stocks f... 
Via StockStory
Topics Artificial Intelligence
News headline image
Natera Spotlights Record Signatera Volumes, Raises Outlook at Canaccord Conference ↗
Natera (NASDAQ:NTRA) Chief Financial Officer Mike Brophy said the company delivered strong second-quarter momentum across its women’s health, oncology and organ health businesses, citing record... 
Via MarketBeat
News headline image
Natera (NTRA) Q2 2026 Earnings Call Transcript ↗
Oncology volumes jumped 57.2% on MRD adoption gains. 
Via The Motley Fool
Topics Earnings
News headline image
5 Insightful Analyst Questions From Natera’s Q2 Earnings Call
Natera’s second quarter results were positively received by the market, driven by robust sales volume growth and ongoing momentum in both established and eme... 
Via StockStory
Topics Earnings
News headline image
What to Know About This Natera Insider Transaction as Shares Surge to Record Highs ↗
Moshkevich's non-discretionary sale was executed to cover tax withholding on vesting RSUs under a Rule 10b5-1 plan. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
A Natera Co-Founder Sold 2,000 Shares From a Spouse's Account. Here's What It Suggests ↗
This sale was executed under a pre-arranged Rule 10b5-1 trading plan. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Should You Worry That a Natera Co-Founder Sold Shares? Here's What Long-Term Investors Should Know ↗
This sale was non-discretionary and executed under a Rule 10b5-1 plan to cover tax withholding from RSU vesting. 
Via The Motley Fool
Topics Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>